| Literature DB >> 30280187 |
Suya Du1, Huirong Liu2, Tiantian Lei3, Xiaofang Xie3, Hailian Wang2, Xia He4, Rongsheng Tong4, Yi Wang4.
Abstract
Mangiferin (1,3,6,7‑tetrahydroxyxanthone‑C2‑β‑D‑glucoside) is a bioactive ingredient predominantly isolated from the mango tree, with potent antioxidant activity and multifactorial pharmacological effects, including antidiabetic, antitumor, lipometabolism regulating, cardioprotective, anti‑hyperuricemic, neuroprotective, antioxidant, anti‑inflammatory, antipyretic, analgesic, antibacterial, antiviral and immunomodulatory effects. Therefore, it possesses several health‑endorsing properties and is a promising candidate for further research and development. However, low solubility, mucosal permeability and bioavailability restrict the development of mangiferin as a clinical therapeutic, and chemical and physical modification is required to expand its application. This review comprehensively analyzed and collectively summarized the primary pharmacological actions of mangiferin that have been demonstrated in the literature, to support the potential future development of mangiferin as a novel therapeutic drug.Entities:
Keywords: mangiferin; harmacological 'activities; ctivecompound; structural modification
Mesh:
Substances:
Year: 2018 PMID: 30280187 DOI: 10.3892/mmr.2018.9529
Source DB: PubMed Journal: Mol Med Rep ISSN: 1791-2997 Impact factor: 2.952